Acetylsalicylic acid as an adjuvant therapy for schizophrenia
2006

Using Aspirin to Help Treat Schizophrenia

Sample size: 80 publication Evidence: moderate

Author Information

Author(s): W. Laan, J. P. Selten, R. S. Kahn, A. M. Huisman, C. J. Heijnen, D. E. Grobbee, H. Burger

Primary Institution: University Medical Center Utrecht

Hypothesis

Does 1000 milligrams of acetylsalicylic acid daily reduce symptoms of schizophrenia?

Conclusion

The study aims to determine if acetylsalicylic acid can improve symptoms of schizophrenia when added to regular antipsychotic treatment.

Supporting Evidence

  • NSAIDs may help prevent deterioration in schizophrenia.
  • Previous studies suggest a link between anti-inflammatory drugs and improved schizophrenia symptoms.
  • Acetylsalicylic acid has neuroprotective effects in animal studies.

Takeaway

The researchers want to see if giving patients with schizophrenia aspirin can help them feel better.

Methodology

A randomized, placebo-controlled, double-blind trial comparing acetylsalicylic acid to placebo over three months.

Potential Biases

Potential biases in participant selection and adherence to treatment.

Limitations

The study may not account for all individual differences in response to treatment.

Participant Demographics

Inpatients and outpatients aged 18-55 with schizophrenia, schizophreniform, or schizoaffective disorder.

Digital Object Identifier (DOI)

10.1186/1745-6215-7-31

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication